2.8400
+0.0050
+(0.18%)
At close: April 15 at 5:35:14 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
17,477
17,477
12,179
4,194
372
Operating Expense
120,142
120,142
69,036
55,368
26,918
Operating Income
-102,665
-102,665
-56,857
-51,174
-26,546
Net Non Operating Interest Income Expense
-4,233
-4,233
-364
-86
152
Other Income Expense
-2,920
-2,920
2,927
1,985
-7,224
Pretax Income
-109,818
-109,818
-54,294
-49,275
-33,618
Tax Provision
607
607
-20
364
--
Net Income Common Stockholders
-110,426
-110,426
-54,274
-49,635
-33,619
Diluted NI Available to Com Stockholders
-110,426
-110,426
-54,274
-49,635
-33,619
Basic EPS
-2.43
-2.43
-1.31
-1.27
-0.99
Diluted EPS
-2.43
-2.43
-1.31
-1.27
-0.99
Basic Average Shares
45,351.7990
45,351.7990
41,449.7320
39,168.1520
33,874.7510
Diluted Average Shares
45,351.7990
45,351.7990
41,449.7320
39,168.1520
33,874.7510
Total Operating Income as Reported
-102,709
-102,709
-57,110
-52,114
-29,718
Total Expenses
120,142
120,142
69,036
55,368
26,918
Net Income from Continuing & Discontinued Operation
-110,426
-110,426
-54,274
-49,635
-33,619
Normalized Income
-109,747.2500
-109,747.2500
-57,199.2438
-51,093.9750
-26,395
Interest Income
991
991
390
57
226
Interest Expense
5,178
5,178
707
138
66
Net Interest Income
-4,233
-4,233
-364
-86
152
EBIT
-104,640
-104,640
-53,587
-49,137
-33,552
EBITDA
-102,041
-102,041
-51,889
-48,961
-31,664
Reconciled Depreciation
2,599
2,599
1,698
-1,288
1,888
Net Income from Continuing Operation Net Minority Interest
-110,426
-110,426
-54,274
-49,635
-33,619
Total Unusual Items Excluding Goodwill
-905
-905
2,927
1,985
-7,224
Total Unusual Items
-905
-905
2,927
1,985
-7,224
Normalized EBITDA
-101,136
-101,136
-54,816
-50,946
-24,440
Tax Rate for Calcs
0.0003
0.0003
0
0.0003
--
Tax Effect of Unusual Items
-226.2500
-226.2500
1.7562
526.0250
--
12/31/2020 - 2/15/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1FW2.F WuXi Biologics (Cayman) Inc.
2.4345
+1.40%
ZR8.F Oncodesign Precision Medicine Société anonyme
0.4250
+0.95%
ALSEN.PA Sensorion SA
0.2980
-1.00%
8EM.F Editas Medicine, Inc.
1.1095
+0.09%
0K4.F Akero Therapeutics, Inc.
32.90
+4.58%
ABVX.PA ABIVAX Société Anonyme
5.27
-1.68%
HYL.BR Hyloris Pharmaceuticals SA
6.58
+9.65%
ARGX.VI argenx SE
530.40
+1.84%
PMN ProMIS Neurosciences, Inc.
0.5600
-6.67%
ARGX.BR argenx SE
530.00
+0.49%